Randomized controlled trial assessed caffeine's effect on hospital stay in moderately preterm infants, suggesting no reduction.
Research Article| September 01 2025 Caffeine Does Not Reduce Hospital Stay for Preterm Infants Available to Purchase AAP Grand Rounds (2025) 54 (3): 29. https://doi.org/10.1542/gr.54-3-29 Views Icon Views Open Menu Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook X LinkedIn Email Tools Icon Tools Open Menu Get Permissions Cite Icon Cite Search Site Citation Caffeine Does Not Reduce Hospital Stay for Preterm Infants. AAP Grand Rounds September 2025; 54 (3): 29. https://doi.org/10.1542/gr.54-3-29 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search toolbar search search input Search input auto suggest filter your search All PublicationsAll JournalsAAP Grand RoundsPediatricsHospital PediatricsPediatrics In ReviewNeoReviewsAAP NewsAll AAP Sites Search Advanced Search Topics: caffeine, infant, premature Source: Carlo WA, Eichenwald EC, Carper BA, et al. Extended caffeine for apnea in moderately preterm infants: the MoCHA randomized clinical trial. JAMA. 2025;333(24):2154-2163; doi: https://doi.org/10.1001/jama.2025.5791.Google Scholar Investigators from multiple institutions conducted a randomized controlled trial to assess the effectiveness of prolonged caffeine administration in reducing the duration of remaining hospitalization in moderately preterm infants. Study participants were infants born at 29 to <34 weeks' gestation who were 33 to <36 weeks postmenstrual age (PMA) at the time of enrollment and being treated at 1 of 29 NICUs in the US. Eligibility criteria included receiving caffeine with plans to discontinue treatment as part of routine clinical care and receiving no respiratory support. Study infants were randomized 1:1 to the prolonged caffeine treatment or placebo group. Those randomized to the caffeine group received caffeine citrate (10/mg/kg/dose) throughout the remainder of their hospitalization and for 28 days after discharge. The primary study outcome was time from randomization until hospital discharge. Secondary outcomes included time until "physiological maturity"—defined as being out of the incubator for >48 hours, receiving ≥140 mL/kg/day of feeds or gaining weight, and being apnea-free for 5 days—and rates of readmission and "sick" outpatient visits in the 8 weeks after discharge. Regression analysis was used to compare outcomes among infants in the caffeine and placebo groups. There were 827 infants enrolled in the study, 416 randomized to caffeine and 411 to the placebo group. Median PMA among infants in the 2 treatment groups at randomization were 34.5 and 34.4 weeks, respectively. The median number of days from randomization to hospital discharge was 18.0 days for those in the caffeine group and 16.5 days for infants randomized to placebo (P >0.99). There also was no significant difference between groups in time to physiologic maturity (median, 14.0 days for caffeine group, 15.0 days for placebo group; adjusted difference, -1 day; 95% confidence interval [CI], -2.4, 0.4). The time to apnea or bradycardia free for 5 days was significantly shorter in those receiving caffeine than in those randomized to placebo (median, 6.0 and 10 days, respectively; adjusted difference, -2.7; 95% CI, -3.4, -2.0), but there were no differences between groups in time to exit from the incubator or time to full feeds (≥140 mL/kg/day) or gaining weight. Following hospitalization, there were no significant differences between groups in rates of readmission or "sick" outpatient visits. The authors conclude that prolonged use of caffeine in moderately preterm infants was not effective in shortening hospitalization. Dr King has disclosed no financial relationship relevant to this commentary. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device. The care of preterm infants in the NICU is costly, primarily driven by length of stay (LOS), and moderately preterm infants account for close to 50% of the total hospitalization costs.1 Recent quality improvement efforts have focused on using NICU care wisely, including opportunities to optimize... You do not currently have access to this content.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: